This announcement contains inside information
C4X Discovery Holdings plc (AIM: C4XD), an innovative drug discovery and development company, today announces that at the General Meeting held earlier today, all the resolutions put to shareholders were duly passed.
As a result, the placing announced on 6 September 2016 of 4,901,961 new ordinary shares at 102 pence per ordinary share to raise £5.0 million, is conditional only on Admission which is expected to take place on 27 September 2016.
Following Admission, the Company's issued share capital will consist of 37,398,718 ordinary shares. There are no ordinary shares held in treasury. Therefore, in accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that following Admission, the total number of voting rights in the Company will be 37,398,718.